Karachi — Welnox, a Martin Dow Group company, announced that it has entered into a licensing partnership with Procter & Gamble (P&G) for Vicks VapoRub, with availability expected to begin in the coming weeks.
This strategic partnership reinforces Martin Dow’s commitment to expand access to high-quality, reliable healthcare solutions for millions of consumers across the country.
5G Rollout Accelerates in Karachi as Active Sites Reach 279 Across Major Networks
For generations, Vicks has been a trusted part of family care routines, offering comforting relief during cough and cold. Backed by over 125 years of heritage, Vicks VapoRub is formulated to help provide relief from common cold symptoms such as nasal congestion, cough, headache, body ache, and discomfort associated with breathing.
Anwar Zaman, CEO, Welnox, said, “Vicks VapoRub is an iconic brand with enduring equity, and a natural fit with our vision to build a strong, consumer-centric healthcare portfolio. We see significant opportunity to build on its strong foundation and unlock new avenues of growth in Pakistan.”
Vicks VapoRub will be available in pharmacies across Pakistan in the coming weeks.
